Warrant
Shares Underlying
Exercise Price
- Type
- Anti-Dilution
- Cashless Exercise
- Expiration
Sector: Computer Peripheral Equipment, NECIndustry: BiotechnologyCountry: USExchange: Nasdaq
DilutionScan read 51 of Ainos, Inc.'s SEC filings and found 6 warrant series, 2 convertibles, 1 ATM program, 2 shelf registrations and 1 completed offering on file for AIMD. The latest dilution event on file is ATM sales on Jul 24, 2026. Analysis updated Oct 16, 2026.
AIMD
Reverse split and tight cash runway
Ainos is a distressed micro-cap transitioning from biotech to AI hardware. While FY 2025 revenue grew 499% to $124K, Q1 2026 revenue collapsed to just $161, showing the business is not yet generating sustainable sales.
Raise routes on file: active ATM + effective shelf · latest dilution event 102 days ago
The dominant contractual driver and its mechanism, then each further driver ranked.
Jul 24, 2026 · ATM Sale
Every warrant, convertible, ATM and shelf, cited to the filing
A free account reads 3 tickers a day in full
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
Shares outstanding, potential dilution and cash over time
Shares Underlying
Exercise Price
Issued 2022
Shares Underlying
Exercise Price
Issued 2022
Shares Underlying
Exercise Price
Shares Underlying
Exercise Price
Issued 2024
Shares Underlying
Exercise Price
Shares Underlying
Exercise Price
Principal
Conversion Price
Principal
Conversion Price
Issued 2024
Total capacity
Sold to date
Issued 2024
Total capacity
Remaining
Issued 2024
Total capacity
Remaining
Gross proceeds
Price per share
Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
DilutionScan ProEvery instrument in full · $59/mo
Covered companies in Biotechnology. All tickers A to Z